Tie-ups of candy makers and nutritional product companies into a single firm called Bettera has culminated in a $1 billion acquisition by Catalent. The global contract manufacturing giant plans to leverage Bettera’s ability to produce gummies and chewables as a way to offer its customers new formulation options for nutraceutical products.
This is the final piece in a three-part series focusing on the role vitamin and mineral supplements can play in supplementing essential vitamins and minerals Americans may not be getting from diet alone.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
This is the final piece in a three-part series focusing on the role vitamin and mineral supplements can play in supplementing essential vitamins and minerals Americans may not be getting from diet alone. Part 1 of this series described the debate over the role vitamin and mineral supplements (VMS, both multiple and single-nutrient) may play in […]
This is a three-part series focusing on the role vitamin and mineral supplements can play in supplementing essential vitamins and minerals Americans may not be getting from diet alone. Part 1 of this series described the debate over the role vitamin and mineral supplements (VMS) may play in reducing the risks for various chronic diseases and how […]
There's little scientific validation behind the multibillion supplement industry - users take pills based on arbitrary whim. Vitagene is building a precision medicine approach - tailoring vitamin regimens to the individual.
People pop prescription pills with an air of caution, but many look at supplements in a different light: They’re icing on the cake, and who knows? Maybe that echinacea will cure Ebola after all. But many supplements can actually be pretty bad for you, as a recent Business Insider story rightly points out. It cites the […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.